John Winkelman, MD, PhD: When to Use Low-Dose Opioids for Restless Legs Syndrome
The first line treatment for restless legs syndrome—dopamine agonists—may be making a patient’s condition worse in the long-term, Winkelman told HCPLive at SLEEP 2024.
The first line treatment for restless legs syndrome—dopamine agonists—may be making a patient’s condition worse in the long-term, Winkelman told HCPLive at SLEEP 2024.
Phase 2 data presented at EULAR 2024 showed gout patients on febuxostat and ruzinurad were more likely to achieve the target serum uric acid level…
The U.S. Food and Drug Administration has begun testing more dairy products for evidence of the bird flu virus as outbreaks spread among dairy herds…
Ever wondered how IoT devices can stay connected globally without breaking the bank? Get ready to uncover the secrets in our discussion with Tarun Gupta,…
Unlock the secrets behind the integration of artificial intelligence and automation in healthcare with Dr. Colin Banas, Chief Medical Officer of Dr First. This episode…
Recognizing administrative harm and combating it with active organizational practices are the necessary first steps to changing the worrisome trajectory of U.S. health care.
This cohort study describes the clinical outcomes of women with BRCA1/2 variant–associated breast cancer who were treated with breast-conserving therapy, including the risk of ipsilateral…
Wisp, a sexual and reproductive telehealth provider, has added a fertility vertical with several partners meant to help birthing people navigate getting pregnant. | The…
Eli Lilly said on Tuesday it will collaborate with OpenAI to leverage its generative AI to develop antimicrobials that can be used to treat drug-resistant…
Despite advancements, care for this rare autoimmune disease is too complex to go it alone
This cohort study examines the association between certain health conditions and lifestyle factors with time to recovery from SARS-CoV-2 infection in a US population-based meta-cohort.